TCL Archive Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities July 28, 2000
TCL Archive Consensus Conference Recommends Adjuvant Chemotherapy In Breast Cancer Only For Premenopausal Women July 25, 1980
TCL Archive NCI Preparing RFA for Genetics Network; Patients Want Gene-Environment Studies August 9, 1996
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
